This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Bortezomib for Injection (2016-03-18)
- Starting date:
- March 18, 2016
- Posting date:
- April 8, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-57860
Affected Products
Bortezomib for Injection
Reason
Potential for presence of particulate matter (glass) in this lot.
Depth of distribution
Wholesalers, hospitals - Quebec, British Columbia, Saskatchewan, Manitoba, Ontario, Newfoundland and Labrador
Affected products
Bortezomib for Injection
DIN, NPN, DIN-HIM
DIN 02423405
Dosage form
Powder for solution
Strength
3.5 mg/vial
Lot or serial number
1600615
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA